VALERIE VAUGHN-SMITH: Open Payments
NPI 1154929735 · KILGORE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 36 payments from 8 companies in 2025. Trend: 2023 $388 · 2024 $729 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $261 |
| E.R. Squibb & Sons, L.L.C. | 6 | $117 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| ABBVIE INC. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
Products named: LYBALVI, COBENFY, ARISTADA, Auvelity, VRAYLAR, UZEDY, REXULTI, CAPLYTA.
Industry payments across TX — which companies pay providers there.
